Skip to Content

Seth Katz

Burg Simpson

Mr. Katz joined Burg Simpson in September 2005 after six years with the New York law firm of Seeger Weiss LLP, in which he was a partner. Mr. Katz focuses his practice primarily in the areas of complex, pharmaceutical mass tort, and class action litigation including consumer protection, securities fraud, products liability, and commercial litigation.

Mr. Katz’s current practice involves primarily complex and class action litigation on behalf of aggrieved consumers, corporate shareholders, and property owners, and pharmaceutical mass tort litigation on behalf of those injured as a result of their ingestion of prescription medications and the implantation of medical devices.

Co-Lead and Interim Class Counsel in Norfolk Southern train in East Palestine, Ohio in In re: East Palestine Train Derailment (No. 4:23-cv-00242).

Plaintiffs’ Executive Committee in In re: Proton Pump Inhibitor Products Liability Litigation (MDL 2789)

Plaintiffs’ Executive Committee in In re: Testosterone Replacement Therapy Products Liability Litigation (MDL 2524)

Co-Lead Counsel In re Pradaxa (Dabigatran Etexilate) Products Liability Litigation (MDL 2385). In May 2014, the Pradaxa MDL announced a $650 million settlement program on behalf of approximately 4,000 claimants after 21 months of litigation.  Mr. Katz was one of the primary negotiators of that settlement.

Plaintiffs’ Steering Committee in the In re DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (MDL 2197.

Mr. Katz was one of the primary attorneys who prosecuted the In re Zyprexa Products Liability Litigation (MDL No. 1956) that resulted in a $700 million settlement

Mr. Katz was born in New York, New York. He obtained a Bachelor of Arts, with distinction, from the University of Michigan in 1990 and earned his law degree, cum laude, from Boston University School of Law in 1993.